Effects of chronic pubertal stressors on mammary gland biology and cancer risk

Information

  • Research Project
  • 10197031
  • ApplicationId
    10197031
  • Core Project Number
    R01CA239719
  • Full Project Number
    5R01CA239719-02
  • Serial Number
    239719
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    7/1/2020 - 3 years ago
  • Project End Date
    6/30/2025 - a year from now
  • Program Officer Name
    GREEN, PAIGE A
  • Budget Start Date
    7/1/2021 - 2 years ago
  • Budget End Date
    6/30/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    9/1/2021 - 2 years ago

Effects of chronic pubertal stressors on mammary gland biology and cancer risk

PROJECT ABSTRACT The developing mammary gland (MG) is vulnerable to environmental and lifestyle risk factors that increase breast cancer (BC) burden in later adulthood. Therefore, optimizing BC prevention and care requires a lifespan approach to identify specific early life risk factors, to understand these risk factors? underlying molecular mechanisms in promoting cancer risk, and to design appropriate interventions that reduce BC in adulthood. Using a Sprague-Dawley rat model of human BC, we have established a dynamic and successful transdisciplinary collaboration among a breast cancer biologist, an endocrinologist, and a biopsychologist to understand how adverse early life exposures lead to increased mammary cancer risk in adulthood. We find that glucocorticoid (GC) reactivity to everyday stressors is heighted by social isolation in puberty and young adulthood and is associated with increased adult mammary cancer burden. Moreover, heightened GC reactivity during puberty impairs ductal development and increases mammary stem cell populations, two characteristics that have been linked to increased mammary cancer. We now propose to determine how heightened GC reactivity disrupts MG development and increases cancer burden by examining the underlying molecular mechanisms connecting glucocorticoid receptor (GR) activation with MG developmental defects (Aim 1). In Aim 2 we will introduce both pharmacological- and social environmental-interventions in early adulthood to reverse heightened stress reactivity. We predict these interventions will restore normal MG ductal differentiation and thereby decrease later cancer risk. In Aim 3, we will examine how heightened GC reactivity during puberty inappropriately preserves mammary stem cell (MaSC) populations that are known to increase later cancer risk. We will also investigate the association between circulating steroid hormone levels, in conjunction with their localized production within the MG microenvironment, and ductal maturation and MaSC biology. Completion of these studies will uncover novel stress-mediated molecular and cellular mechanisms of disrupted MG development linked to subsequent mammary cancer and determine whether these stress- mediated events are reversible with early adulthood interventions.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    419270
  • Indirect Cost Amount
    147155
  • Total Cost
    566425
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    393
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NCI:566425\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    MESH
  • Study Section Name
    Biobehavioral Mechanisms of Emotion, Stress and Health Study Section
  • Organization Name
    UNIVERSITY OF CHICAGO
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    005421136
  • Organization City
    CHICAGO
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    606372612
  • Organization District
    UNITED STATES